Apuli Maricel

Track

Insider profile

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 47% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Apuli Maricel's trades of BridgeBio Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-04 2026-04-30
PlS Planned sale
2,539 -27.8%
319.20
US$4,264,770 		2,539 -27.8% 319.20 US$4,264,770
2026-02-27 2026-02-26
PlS Planned sale
9,282 +44.0%
125.55
US$3,466,287 		9,282 +44.0% 125.55 US$3,466,287
2026-02-18 2026-02-17
PlS Planned sale
27,853 +37.7%
238.74
US$4,745,391 		27,853 +37.7% 238.74 US$4,745,391
2025-12-10 2025-12-08
PlS Planned sale
2,000 -1.5%
74.26
US$148,520 		2,000 -1.5% 74.26 US$148,520
2025-08-11 2025-08-07
S Sale
1,000 -0.7%
45.44
US$45,440 		1,000 -0.7% 45.44 US$45,440
2025-05-06 2025-05-02
S Sale
1,026 -0.7%
38.51
US$39,509 		1,026 -0.7% 38.51 US$39,509